Adamas Pharmaceuticals
ADMS
#7201
Rank
NZ$0.63 B
Marketcap
$13.78
Share price
0.00%
Change (1 day)
16,254.51%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -NZ$54.73 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are NZ$88.18 Million. In 2020 the company made an earning of -NZ$73.52 Million, an increase over its 2019 earnings that were of -NZ$0.16 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$54.73 Million-25.55%
2020-NZ$73.52 Million-51.34%
2019-NZ$0.16 Billion-19.45%
2018-NZ$0.19 Billion28.96%
2017-NZ$0.15 Billion42.3%
2016-NZ$0.11 Billion6.18%
2015-NZ$96.26 Million-410.24%
2014NZ$31.02 M-67.53%
2013NZ$95.55 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.36 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.22 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.36 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$35.54 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA